Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

NCT00750269

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Center for Cancer Care - Peoria Peoria, Arizona, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center Burbank, California, United States
  • Radiation Oncology Centers - Cameron Park Cameron Park, California, United States
View all 58 locations
View Trial Details
Completed

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

NCT03717155

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Semmelweis Egyetem - Pulmonologiai Klinika Budapest, Hungary
  • Debreceni Egyetem - Tudogyogyaszati Klinika Debrecen, Hungary
  • Petz Aladar Megyei Oktato Korhaz - Pulmonologiai Osztaly Győr, Hungary
  • Markusovszky Egyetemi Oktatokorhaz Szombathely, Hungary
View all 20 locations
View Trial Details
Completed

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

NCT02684461

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UNC Lineberger Comprehsive Cancer Center Chapel Hill, North Carolina, United States
  • Rex Cancer Center Raleigh, North Carolina, United States
  • Rex Cancer Center of Wakefield Raleigh, North Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

NCT03790397

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, Galicia, Spain
  • Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain
  • Hospital Universitario Dr. Negrín Las Palmas de Gran Canaria, Las Palmas, Spain
View all 31 locations
View Trial Details
Completed

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

NCT03270176

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cross Cancer Center Dept Medicine Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital Cancer Centre (TOHCC) Ottawa, Ontario, Canada
View Trial Details
Completed

Immune Boost In Non-Small Cell Lung Cancer

NCT02319408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg Heidelberg, Germany
  • German Cancer Research Centre and Clinic for Radiation Oncology of the University of Heidelberg Heidelberg, Germany
View Trial Details

Related conditions